Zepzelca OverviewLurbinectedin, sold under the brand name Zepzelca, is a medication for the treatment of adults with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. The most common side effects include leukopenia, lymphopenia, fatigue, anemia, neutropenia, increased creatinine, increased alanine aminotransferase, increased glucose, thrombocytopenia, nausea, decreased appetite, musculoskeletal pa...
Read more Zepzelca Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lurbinectedin
Recent Zepzelca Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Powder: 4mg/vial
NDC Database Records for Zepzelca: (1 result)Sorted by National Drug Code
- 68727-712 Zepzelca .5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Jazz Pharmaceuticals, Inc.